A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-04-03) →
What happened
Dongsung Pharmaceutical disclosed convertible bonds to raise US$33.1M, about 40.3% of its market value.
For context, this raise equals about 40.3% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | US$33.1M |
| vs. market value | 40.3% |
| Filed | 2026-04-01, Material event report (convertible bonds) |
| Source | DART rcept 20260401004789 → open original filing |
Versions of this filing
- 2026-04-01Original (this page)
- 2026-04-03Amendment 1
Source: DART. Information only, not investment advice.